Statin use and rupture of abdominal aortic aneurysm

British Journal of Surgery

Volumn 101, Issue 8, 2014, Pages 966-975

  Wemmelund, H ^a,b   Hogh A ^a   Hundborg, H H ^b   Thomsen, R W ^b   Johnsen, S P ^b   Lindholt, J S ^a,c  

^a VIBORG HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA ANEURYSM; AGED; AORTA RUPTURE; ARTICLE; CASE CONTROL STUDY; DENMARK; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MORTALITY; SOCIOECONOMICS; STATISTICS;

AGED; AORTIC ANEURYSM, ABDOMINAL; AORTIC RUPTURE; CASE-CONTROL STUDIES; DENMARK; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; SOCIOECONOMIC FACTORS;

EID: 84902281913     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9517     Document Type: Article

References (41)

1. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, et al.; Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002; 360: 1531-1539.
2. Lindholt JS, Juul S, Fasting H, Henneberg EW,. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ 2005; 330: 750.
3. Darwood R, Earnshaw JJ, Turton G, Shaw E, Whyman M, Poskitt K, et al. Twenty-year review of abdominal aortic aneurysm screening in men in the county of Gloucestershire, United Kingdom. J Vasc Surg 2012; 56: 8-13.
4. Lederle FA, Johnson GR, Wilson SE, Ballard DJ, Jordan WD Jr, Blebea J, et al.; Veterans Affairs Cooperative Study #417 Investigators. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 2002; 287: 2968-2672.
5. Glimåker H, Holmberg L, Elvin A, Nybacka O, Almgren B, Björck CG, et al. Natural history of patients with abdominal aortic aneurysm. Eur J Vasc Surg 1991; 5: 125-130.
6. Grootenboer N, van Sambeek MR, Arends LR, Hendriks JM, Hunink MG, Bosch JL,. Systematic review and meta-analysis of sex differences in outcome after intervention for abdominal aortic aneurysm. Br J Surg 2010; 97: 1169-1179.
7. Lindholt JS, Søgaard R, Laustsen J,. Prognosis of ruptured abdominal aortic aneurysms in Denmark from 1994-2008. Clin Epidemiol 2012; 4: 111-113.
8. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.
9. Liao JK,. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 2005; 96: 24F-33F.
10. Liao JK, Laufs U,. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005; 45: 89-118.
11. Takagi H, Yamamoto H, Iwata K, Goto S, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational comparative studies. Eur J Vasc Endovasc Surg 2012; 44: 287-292.
12. Sweeting MJ, Thompson SG, Brown LC, Powell JT,; RESCAN collaborators. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg 2012; 99: 655-665.
13. Moll FL, Powell JT, Fraedrich G, Verzini F, Haulon S, Waltham M, et al.; European Society for Vascular Surgery. Management of abdominal aortic aneurysms clinical practice guidelines of the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg 2011; 41 (Suppl 1): S1-S58.
14. Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sicard GA, et al. The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. J Vasc Surg 2009; 50 (Suppl): S2-S49.
15. Eldrup N, Budtz-Lilly J, Laustsen J, Bibby BM, Paaske WP,. Long-term incidence of myocardial infarct, stroke, and mortality in patients operated on for abdominal aortic aneurysms. J Vasc Surg 2012; 55: 311-317.
16. Schmidt H, Hennen R, Keller A, Russ M, Müller-Werdan U, Werdan K, et al,. Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med 2006; 32: 1248-1251.
17. Efron DT, Sorock G, Haut ER, Chang D, Schneider E, Mackenzie E, et al. Preinjury statin use is associated with improved in-hospital survival in elderly trauma patients. J Trauma 2008; 64: 66-73.
18. Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B,. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006; 105: 1260-1272.
19. Feeney JM, Jayaraman V, Spilka J, Shapiro DS, Ellner S, Marshall WT, et al. Prehospital HMG Co-A reductase inhibitor use and reduced mortality in hemorrhagic shock due to trauma. Eur J Trauma Emerg Surg 2012; 38: 171-176.
20. Feeney JM, Burns K, Staff I, Bai J, Rodrigues N, Fortier J, et al. Prehospital HMG Co-A reductase inhibitor use and reduced mortality in ruptured abdominal aortic aneurysm. J Am Coll Surg 2009; 209: 41-46.
21. McNally MM, Agle SC, Parker FM, Bogey WM, Powell CS, Stoner MC,. Preoperative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair. J Vasc Surg 2010; 51: 1390-1396.
22. Pedersen CB, Gøtzsche H, Moller JO, Mortensen PB,. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006; 53: 441-449.
23. Kildemoes HW, Sørensen HT, Hallas J,. The Danish National Prescription Registry. Scand J Public Health 2011; 39: 38-41.
24. WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health. ATC/DDD Index 2013. http://www.whocc.no/atc-ddd- index/ 2013 [accessed 1 December 2013].
25. Hackam DG, Thiruchelvam D, Redelmeier DA,. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet 2006; 368: 659-665.
26. Liao S, Miralles M, Kelley BJ, Curci JA, Borhani M, Thompson RW,. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J Vasc Surg 2001; 33: 1057-1064.
27. Daugherty A, Cassis L,. Angiotensin II and abdominal aortic aneurysms. Curr Hypertens Rep 2004; 6: 442-446.
28. Daugherty A, Manning MW, Cassis LA,. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000; 105: 1605-1612.
29. Slaiby JM, Ricci MA, Gadowski GR, Hendley ED, Pilcher DB,. Expansion of aortic aneurysms is reduced by propranolol in a hypertensive rat model. J Vasc Surg 1994; 20: 178-183.
30. Gadowski GR, Pilcher DB, Ricci MA,. Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg 1994; 19: 727-731.
31. Wilmink AB, Vardulaki KA, Hubbard CS, Day NE, Ashton HA, Scott AP, et al. Are antihypertensive drugs associated with abdominal aortic aneurysms? J Vasc Surg 2002; 36: 751-757.
32. Andersen JS, Olivarius Nde F, Krasnik A,. The Danish National Health Service Register. Scand J Public Health 2011; 39: 34-37.
33. Schneeweiss S., Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf 2006; 15: 291-303.
34. Lash TL, Fox MP, Fink AK,. Applying Quantitative Bias Analysis to Epidemiologic Data. Springer: Dordrecht, 2009.
35. Lash TL, Fox MP, Fink AK,. bias.analysis. https://sites.google.com/site/ biasanalysis [accessed 1 April 2013].
36. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
37. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT,. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011; 11: 83.
38. Dublin S, Jackson ML, Nelson JC, Weiss NS, Larson EB, Jackson LA,. Statin use and risk of community acquired pneumonia in older people: population based case-control study. BMJ 2009; 338: b2137.
39. Patrick AR, Shrank WH, Glynn RJ, Solomon DH, Dormuth CR, Avorn J, et al. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value Health 2011; 14: 513-520.
40. Thomsen RW, Nielsen RB, Nørgaard M, Horsdal HT, Stürmer T, Larsen FB, et al. Lifestyle profile among statin users. Epidemiology 2013; 24: 619-620.
41. Sever PS, Chang CL, Gupta AK, Whitehouse A, Poulter NR,; ASCOT Investigators. The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K. Eur Heart J 2011; 32: 2525-2532.